Heart Failure Therapies following Acute Coronary Syndromes with Reduced Ejection Fraction: Data from the ACSIS Survey.

Barak Zafrir,Tal Ovdat, Mahmood Abu Akel,Fadel Bahouth,Katia Orvin,Roy Beigel,Offer Amir,Gabby Elbaz-Greener

Journal of personalized medicine（2023）

引用 0|浏览6

暂无评分

摘要

In current clinical practice, the majority of patients with reduced and mildly-reduced LVEF are treated by ACEI/ARB and beta-blockers early following ACS, whereas MRA is underutilized and the adoption of SGLT2I and ARNI is low. A greater number of therapeutic classes was not associated with reduced short-term rehospitalizations or mortality.

查看译文

关键词

heart failure, myocardial infarction, left ventricular dysfunction, drug therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要